US5605798A
(en)
*
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
CA2153387A1
(en)
|
1993-01-07 |
1994-07-21 |
Hubert Koester |
Dna sequencing by mass spectrometry
|
US6194144B1
(en)
|
1993-01-07 |
2001-02-27 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
US6146854A
(en)
*
|
1995-08-31 |
2000-11-14 |
Sequenom, Inc. |
Filtration processes, kits and devices for isolating plasmids
|
AU2069597A
(en)
|
1996-03-04 |
1997-09-22 |
Genetrace Systems, Inc. |
Methods of screening nucleic acids using mass spectrometry
|
US6214555B1
(en)
*
|
1996-05-01 |
2001-04-10 |
Visible Genetics Inc. |
Method compositions and kit for detection
|
US6022688A
(en)
|
1996-05-13 |
2000-02-08 |
Sequenom, Inc. |
Method for dissociating biotin complexes
|
US5777324A
(en)
|
1996-09-19 |
1998-07-07 |
Sequenom, Inc. |
Method and apparatus for maldi analysis
|
US5965363A
(en)
|
1996-09-19 |
1999-10-12 |
Genetrace Systems Inc. |
Methods of preparing nucleic acids for mass spectrometric analysis
|
US7285422B1
(en)
|
1997-01-23 |
2007-10-23 |
Sequenom, Inc. |
Systems and methods for preparing and analyzing low volume analyte array elements
|
US6140053A
(en)
*
|
1996-11-06 |
2000-10-31 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry via exonuclease degradation
|
US6133436A
(en)
|
1996-11-06 |
2000-10-17 |
Sequenom, Inc. |
Beads bound to a solid support and to nucleic acids
|
EP1164203B1
(de)
*
|
1996-11-06 |
2007-10-10 |
Sequenom, Inc. |
DNA-Diagnostik mittels Massenspektrometrie
|
DE69735445T2
(de)
|
1996-12-10 |
2006-08-10 |
Sequenom, Inc., San Diego |
Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung
|
DE19653439A1
(de)
*
|
1996-12-20 |
1998-07-02 |
Svante Dr Paeaebo |
Verfahren zur direkten, exponentiellen Amplifikation und Sequenzierung von DNA Molekülen und dessen Anwendung
|
US6399304B1
(en)
|
1996-12-20 |
2002-06-04 |
Roche Diagnostics Gmbh |
Sequential activation of one or more enzymatic activities within a thermocycling reaction for synthesizing DNA molecules
|
US6828094B2
(en)
*
|
1996-12-20 |
2004-12-07 |
Roche Diagnostics Gmbh |
Method for the uncoupled, direct, exponential amplification and sequencing of DNA molecules with the addition of a second thermostable DNA polymerase and its application
|
DE19653494A1
(de)
*
|
1996-12-20 |
1998-06-25 |
Svante Dr Paeaebo |
Verfahren zur entkoppelten, direkten, exponentiellen Amplifikation und Sequenzierung von DNA Molekülen unter Zugabe einer zweiten thermostabilen DNA Polymerase und dessen Anwendung
|
EP2202312B1
(de)
|
1997-03-12 |
2016-01-06 |
Applied Biosystems, LLC |
DNA-Polymerase mit verbesserten etikettierten Nucleotideinbindungseigenschaften
|
US6207370B1
(en)
|
1997-09-02 |
2001-03-27 |
Sequenom, Inc. |
Diagnostics based on mass spectrometric detection of translated target polypeptides
|
US20110166040A1
(en)
*
|
1997-09-05 |
2011-07-07 |
Ibis Biosciences, Inc. |
Compositions for use in identification of strains of e. coli o157:h7
|
EP1816197B1
(de)
*
|
1998-04-23 |
2009-09-16 |
Takara Bio Inc. |
Methode für DNA synthese
|
US7875440B2
(en)
|
1998-05-01 |
2011-01-25 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US6780591B2
(en)
|
1998-05-01 |
2004-08-24 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US20030138834A1
(en)
*
|
1998-08-19 |
2003-07-24 |
Dawson Elliott P. |
Method for determining polynucleotide sequence variations
|
AU737087C
(en)
*
|
1998-08-19 |
2005-05-12 |
Bioventures, Inc. |
Method for determining polynucleotide sequence variations
|
US20040121394A1
(en)
*
|
1998-08-19 |
2004-06-24 |
Dawson Elliott P. |
Method for determining polynucleotide sequence variations
|
AU774306B2
(en)
*
|
1999-01-05 |
2004-06-24 |
Trustees Of Boston University |
Improved nucleic acid cloning
|
US6225061B1
(en)
|
1999-03-10 |
2001-05-01 |
Sequenom, Inc. |
Systems and methods for performing reactions in an unsealed environment
|
US6395486B1
(en)
|
1999-03-15 |
2002-05-28 |
Applera Corporation |
Probe/mobility modifier complexes for multiplexnucleic acid detection
|
US20020009394A1
(en)
|
1999-04-02 |
2002-01-24 |
Hubert Koster |
Automated process line
|
ATE490777T1
(de)
|
1999-06-01 |
2010-12-15 |
Baylor College Medicine |
Zusammensetzungen und verfahren zur therapeutischen anwendung einer mit dem gen atonal assoziierten sequenz
|
US7501245B2
(en)
|
1999-06-28 |
2009-03-10 |
Helicos Biosciences Corp. |
Methods and apparatuses for analyzing polynucleotide sequences
|
US6942964B1
(en)
*
|
1999-07-09 |
2005-09-13 |
Sigma-Aldrich Co. |
Tracer reagents that enhance reaction-product analysis
|
US20020045182A1
(en)
*
|
1999-07-16 |
2002-04-18 |
Lynx Therapeutics, Inc. |
Multiplexed differential displacement for nucleic acid determinations
|
EP1218546A4
(de)
*
|
1999-09-30 |
2005-01-05 |
New England Biolabs Inc |
Einbau von modifizierten nukleotiden durch die archaeon-dna-polymerasen und damit zusammenhängende methoden
|
KR20020064298A
(ko)
|
1999-10-13 |
2002-08-07 |
시쿼넘, 인코포레이티드 |
다형성 유전 마커를 동정하기 위한 데이타베이스 및 이의제조 방법
|
US7332275B2
(en)
|
1999-10-13 |
2008-02-19 |
Sequenom, Inc. |
Methods for detecting methylated nucleotides
|
US7917301B1
(en)
|
2000-09-19 |
2011-03-29 |
Sequenom, Inc. |
Method and device for identifying a biological sample
|
US20030207297A1
(en)
*
|
1999-10-13 |
2003-11-06 |
Hubert Koster |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
CN1336960A
(zh)
*
|
1999-11-26 |
2002-02-20 |
株式会社百尼尔 |
采用多种dna聚合酶的dna测序方法和所用的试剂盒
|
DE10010282B4
(de)
|
2000-02-25 |
2006-11-16 |
Epigenomics Ag |
Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben
|
ATE423221T1
(de)
|
2000-06-13 |
2009-03-15 |
Univ Boston |
Verwendung von mass-matched nukleotide in der analyse von oligonukleotidmischungen sowie in der hoch-multiplexen nukleinsäuresequenzierung
|
AU2001273337B2
(en)
|
2000-07-10 |
2006-06-29 |
Board Of Regents, The University Of Texas System |
Chromosome 3p21.3 genes are tumor suppressors
|
GB0021286D0
(en)
*
|
2000-08-30 |
2000-10-18 |
Gemini Genomics Ab |
Identification of drug metabolic capacity
|
US20020142483A1
(en)
|
2000-10-30 |
2002-10-03 |
Sequenom, Inc. |
Method and apparatus for delivery of submicroliter volumes onto a substrate
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
DE60224383T3
(de)
|
2001-02-15 |
2012-06-28 |
The University Of Chicago |
Verfahren zum nachweis in hefe für mittel die proteinfaltung beeinflussen
|
US20040121310A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in forensic studies
|
US20030027135A1
(en)
|
2001-03-02 |
2003-02-06 |
Ecker David J. |
Method for rapid detection and identification of bioagents
|
US20040121313A1
(en)
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in organs for transplantation
|
US20040121314A1
(en)
*
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in containers
|
WO2004060278A2
(en)
|
2002-12-06 |
2004-07-22 |
Isis Pharmaceuticals, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US7718354B2
(en)
|
2001-03-02 |
2010-05-18 |
Ibis Biosciences, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US7666588B2
(en)
|
2001-03-02 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
|
US7226739B2
(en)
|
2001-03-02 |
2007-06-05 |
Isis Pharmaceuticals, Inc |
Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
|
CA2440754A1
(en)
*
|
2001-03-12 |
2002-09-19 |
Stephen Quake |
Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension
|
US20020155587A1
(en)
|
2001-04-20 |
2002-10-24 |
Sequenom, Inc. |
System and method for testing a biological sample
|
US8073627B2
(en)
|
2001-06-26 |
2011-12-06 |
Ibis Biosciences, Inc. |
System for indentification of pathogens
|
US7217510B2
(en)
|
2001-06-26 |
2007-05-15 |
Isis Pharmaceuticals, Inc. |
Methods for providing bacterial bioagent characterizing information
|
DE10132785A1
(de)
*
|
2001-07-06 |
2003-01-16 |
Clondiag Chip Tech Gmbh |
Verfahren zum Nachweis von in einer Polymerase-Kettenreaktion amplifizierten Nukleinsäuremolekülen
|
WO2003092581A2
(en)
*
|
2001-07-16 |
2003-11-13 |
Hk Pharmaceuticals, Inc. |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
CA2456169C
(en)
*
|
2001-08-02 |
2012-05-22 |
Didier Trono |
Methods and compositions relating to improved lentiviral vector production systems
|
AU2002324909A1
(en)
*
|
2001-09-07 |
2003-03-24 |
Baylor College Of Medicine |
Linear dna fragments for gene expression
|
US20050042629A1
(en)
|
2002-09-13 |
2005-02-24 |
Applera Corporation |
Thermus scotoductus nucleic acid polymerases
|
KR20040054699A
(ko)
*
|
2001-10-02 |
2004-06-25 |
엥스띠뛰 끌레이톤 드 라 러쉐르쉬 |
제한된 발현의 렌티바이러스 벡터 및 이의 적용과 관련된방법 및 조성물
|
US20030224380A1
(en)
*
|
2001-10-25 |
2003-12-04 |
The General Hospital Corporation |
Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
|
US20030170678A1
(en)
*
|
2001-10-25 |
2003-09-11 |
Neurogenetics, Inc. |
Genetic markers for Alzheimer's disease and methods using the same
|
AU2002364945A1
(en)
*
|
2001-10-25 |
2003-07-09 |
Neurogenetics, Inc. |
Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
|
AU2002348417B9
(en)
|
2001-10-26 |
2010-02-04 |
Baylor College Of Medicine |
A composition and method to alter lean body mass and bone properties in a subject
|
WO2003036263A2
(en)
*
|
2001-10-26 |
2003-05-01 |
Sequenom, Inc. |
Method and apparatus for parallel dispensing of defined volumes of solid particles
|
US7256016B2
(en)
*
|
2001-11-02 |
2007-08-14 |
Rice University |
Recycling system for manipulation of intracellular NADH availability
|
WO2003048308A2
(en)
|
2001-11-30 |
2003-06-12 |
Applera Corporation |
Thermus brockianus nucleic acid polymerases
|
BR0214869A
(pt)
|
2001-12-11 |
2005-03-08 |
Advisys Inc |
Suplementação mediada por plasmìdeo para tratamento de indivìduos cronicamente doentes
|
CA2475003A1
(en)
|
2002-02-01 |
2003-08-07 |
Sequitur, Inc. |
Double-stranded oligonucleotides
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
US20030166282A1
(en)
|
2002-02-01 |
2003-09-04 |
David Brown |
High potency siRNAS for reducing the expression of target genes
|
CA2475785A1
(en)
*
|
2002-02-12 |
2003-08-21 |
Applera Corporation |
Polymerase compositions
|
DK1502102T3
(da)
*
|
2002-03-11 |
2009-05-04 |
Caprotec Bioanalytics Gmbh |
Forbindelser og fremgangsmåder til analysering af proteomet
|
US8338168B2
(en)
*
|
2002-04-26 |
2012-12-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Chimeric glycoproteins and pseudotyped lentiviral vectors
|
WO2003093303A1
(en)
|
2002-05-06 |
2003-11-13 |
Board Of Regents, The University Of Texas System |
Targeting proteins to deliver therapeutic or diagnostic reagents
|
US20030220844A1
(en)
*
|
2002-05-24 |
2003-11-27 |
Marnellos Georgios E. |
Method and system for purchasing genetic data
|
WO2003101177A2
(en)
*
|
2002-06-04 |
2003-12-11 |
Sequenom, Inc. |
Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
|
WO2004002295A2
(en)
*
|
2002-06-27 |
2004-01-08 |
Sequenom, Inc. |
Diagnosing predisposition to fat deposition and associated condition
|
WO2004002296A2
(en)
*
|
2002-06-27 |
2004-01-08 |
Sequenom, Inc. |
Therapeutic methods for reducing fat deposition and treating associated conditions
|
US6916474B2
(en)
|
2002-07-15 |
2005-07-12 |
Board Of Regents, The University Of Texas System |
Antibodies with increased affinities for anthrax antigens
|
US20080176812A1
(en)
*
|
2002-08-05 |
2008-07-24 |
Davidson Beverly L |
Allele-specific silencing of disease genes
|
US20050042646A1
(en)
*
|
2002-08-05 |
2005-02-24 |
Davidson Beverly L. |
RNA interference suppresion of neurodegenerative diseases and methods of use thereof
|
US20040241854A1
(en)
|
2002-08-05 |
2004-12-02 |
Davidson Beverly L. |
siRNA-mediated gene silencing
|
US20050106731A1
(en)
*
|
2002-08-05 |
2005-05-19 |
Davidson Beverly L. |
siRNA-mediated gene silencing with viral vectors
|
US20080274989A1
(en)
|
2002-08-05 |
2008-11-06 |
University Of Iowa Research Foundation |
Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
|
US20050255086A1
(en)
*
|
2002-08-05 |
2005-11-17 |
Davidson Beverly L |
Nucleic acid silencing of Huntington's Disease gene
|
US20040023390A1
(en)
*
|
2002-08-05 |
2004-02-05 |
Davidson Beverly L. |
SiRNA-mediated gene silencing with viral vectors
|
KR101170653B1
(ko)
|
2002-08-12 |
2012-08-03 |
제네렉스, 인코포레이티드 |
폭스바이러스 및 암과 관련된 방법 및 조성물
|
US20040109853A1
(en)
*
|
2002-09-09 |
2004-06-10 |
Reactive Surfaces, Ltd. |
Biological active coating components, coatings, and coated surfaces
|
US20050277118A1
(en)
*
|
2002-09-11 |
2005-12-15 |
Roth Richard B |
Methods for identifying subjects at risk of melanoma and treatments thereof
|
EP1604009A4
(de)
*
|
2002-11-06 |
2007-06-20 |
Sequenom Inc |
Verfahren zur identifizierung des melanomrisikos und behandlungen davon
|
DK1563069T3
(da)
*
|
2002-11-22 |
2012-07-23 |
Inst Clayton De La Rech |
Sammensætninger og systemer til genregulering
|
AU2003293130A1
(en)
*
|
2002-11-25 |
2004-06-18 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
US7510835B2
(en)
*
|
2002-11-25 |
2009-03-31 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
AU2003298742A1
(en)
*
|
2002-11-25 |
2004-06-18 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
WO2004050839A2
(en)
*
|
2002-11-27 |
2004-06-17 |
Sequenom, Inc. |
Fragmentation-based methods and systems for sequence variation detection and discovery
|
WO2004064972A2
(en)
*
|
2003-01-16 |
2004-08-05 |
Hk Pharmaceuticals, Inc. |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
US7312202B2
(en)
|
2003-02-18 |
2007-12-25 |
Board Of Regents, The University Of Texas System |
Rationally designed and chemically synthesized promoter for genetic vaccine and gene therapy
|
WO2004081040A2
(en)
|
2003-03-12 |
2004-09-23 |
Advisys, Inc. |
Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
|
US8046171B2
(en)
|
2003-04-18 |
2011-10-25 |
Ibis Biosciences, Inc. |
Methods and apparatus for genetic evaluation
|
TW200424214A
(en)
*
|
2003-04-21 |
2004-11-16 |
Advisys Inc |
Plasmid mediated GHRH supplementation for renal failures
|
EP1618216A2
(de)
*
|
2003-04-25 |
2006-01-25 |
Sequenom, Inc. |
Auf fragmentierung beruhende verfahren und systeme zur de-novo-sequenzierung
|
US8057993B2
(en)
|
2003-04-26 |
2011-11-15 |
Ibis Biosciences, Inc. |
Methods for identification of coronaviruses
|
US7964343B2
(en)
|
2003-05-13 |
2011-06-21 |
Ibis Biosciences, Inc. |
Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US8158354B2
(en)
|
2003-05-13 |
2012-04-17 |
Ibis Biosciences, Inc. |
Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US7572581B2
(en)
*
|
2003-06-30 |
2009-08-11 |
Roche Molecular Systems, Inc. |
2′-terminator nucleotide-related methods and systems
|
CN1894581B
(zh)
|
2003-07-09 |
2012-02-01 |
生命技术公司 |
检测蛋白-蛋白相互作用的方法
|
US20070224615A1
(en)
*
|
2003-07-09 |
2007-09-27 |
Invitrogen Corporation |
Methods for assaying protein-protein interactions
|
US20050233341A1
(en)
*
|
2003-07-23 |
2005-10-20 |
Roth Richard R |
Methods for identifying risk of melanoma and treatments thereof
|
US20050272043A1
(en)
*
|
2003-07-24 |
2005-12-08 |
Roth Richard B |
Methods for identifying risk of breast cancer and treatments thereof
|
US20050059024A1
(en)
|
2003-07-25 |
2005-03-17 |
Ambion, Inc. |
Methods and compositions for isolating small RNA molecules
|
EP1654361B2
(de)
|
2003-07-25 |
2023-01-18 |
Life Technologies Corporation |
Verfahren und zusammensetzungen zur herstellung von rna aus einer fixierten probe
|
DK1660680T3
(da)
|
2003-07-31 |
2009-06-22 |
Sequenom Inc |
Fremgangsmåde til multipleks-polymerasekædereaktioner på höjt niveau og homogene masseforlængelsesreaktioner til genotypebestemmelse af polymorfismer
|
WO2005019476A1
(en)
*
|
2003-08-20 |
2005-03-03 |
Applera Corporation |
Polymerase compositions
|
US9394565B2
(en)
*
|
2003-09-05 |
2016-07-19 |
Agena Bioscience, Inc. |
Allele-specific sequence variation analysis
|
US8546082B2
(en)
|
2003-09-11 |
2013-10-01 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US20120122096A1
(en)
|
2003-09-11 |
2012-05-17 |
Rangarajan Sampath |
Compositions for use in identification of bacteria
|
US20100129811A1
(en)
*
|
2003-09-11 |
2010-05-27 |
Ibis Biosciences, Inc. |
Compositions for use in identification of pseudomonas aeruginosa
|
US8097416B2
(en)
|
2003-09-11 |
2012-01-17 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US7169560B2
(en)
|
2003-11-12 |
2007-01-30 |
Helicos Biosciences Corporation |
Short cycle methods for sequencing polynucleotides
|
US8163895B2
(en)
|
2003-12-05 |
2012-04-24 |
Ibis Biosciences, Inc. |
Compositions for use in identification of orthopoxviruses
|
US20060141487A1
(en)
*
|
2004-01-26 |
2006-06-29 |
Applera Corporation |
Methods, compositions, and kits for amplifying and sequencing polynucleotides
|
US7666592B2
(en)
|
2004-02-18 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for concurrent identification and quantification of an unknown bioagent
|
EP2248911A1
(de)
|
2004-02-19 |
2010-11-10 |
Helicos Biosciences Corporation |
Verfahren und Zusammensetzungen zur Analyse von Polynukleotidsequenzen
|
US8119336B2
(en)
|
2004-03-03 |
2012-02-21 |
Ibis Biosciences, Inc. |
Compositions for use in identification of alphaviruses
|
AU2005230936B2
(en)
*
|
2004-03-26 |
2010-08-05 |
Agena Bioscience, Inc. |
Base specific cleavage of methylation-specific amplification products in combination with mass analysis
|
US7608394B2
(en)
|
2004-03-26 |
2009-10-27 |
Sequenom, Inc. |
Methods and compositions for phenotype identification based on nucleic acid methylation
|
WO2006073472A2
(en)
|
2004-05-21 |
2006-07-13 |
Mo Bio Laboratories, Inc. |
Kits and processes for removing contaminants from nucleic acids in environmental and biological samples
|
EP2458619B1
(de)
|
2004-05-24 |
2017-08-02 |
Ibis Biosciences, Inc. |
Massenspektrometrie mit selektivem Ionfilter durch digitale Schwelle
|
US20050266411A1
(en)
|
2004-05-25 |
2005-12-01 |
Hofstadler Steven A |
Methods for rapid forensic analysis of mitochondrial DNA
|
WO2005118856A1
(en)
*
|
2004-05-27 |
2005-12-15 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
US7811753B2
(en)
|
2004-07-14 |
2010-10-12 |
Ibis Biosciences, Inc. |
Methods for repairing degraded DNA
|
CA2574572A1
(en)
*
|
2004-07-19 |
2006-10-26 |
Baylor College Of Medicine |
Modulation of cytokine signaling regulators and applications for immunotherapy
|
CA2574610A1
(en)
*
|
2004-07-22 |
2006-03-02 |
Sequenom, Inc. |
Methods for identifying risk of type ii diabetes and treatments thereof
|
US20060073501A1
(en)
*
|
2004-09-10 |
2006-04-06 |
Van Den Boom Dirk J |
Methods for long-range sequence analysis of nucleic acids
|
ES2345993T3
(es)
|
2004-09-14 |
2010-10-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Metodo para el tratamiento con bucindolol basado en direccionamiento genetico.
|
WO2006089152A2
(en)
*
|
2005-02-18 |
2006-08-24 |
Maxcyte, Inc. |
Use of methyltransferase inhibitors to enhance transgene expression
|
US8084207B2
(en)
|
2005-03-03 |
2011-12-27 |
Ibis Bioscience, Inc. |
Compositions for use in identification of papillomavirus
|
WO2006094238A2
(en)
|
2005-03-03 |
2006-09-08 |
Isis Pharmaceuticals, Inc. |
Compositions for use in identification of adventitious viruses
|
US20060286006A1
(en)
*
|
2005-06-21 |
2006-12-21 |
Mcdaniel C S |
Method and apparatus for the treatment of fluid waste streams
|
US7868159B2
(en)
*
|
2005-06-23 |
2011-01-11 |
Baylor College Of Medicine |
Modulation of negative immune regulators and applications for immunotherapy
|
CA2616281C
(en)
|
2005-07-21 |
2014-04-22 |
Isis Pharmaceuticals, Inc. |
Methods for rapid identification and quantitation of mitochondrial dna variants
|
US20070026012A1
(en)
|
2005-08-01 |
2007-02-01 |
Cornell Research Foundation, Inc. |
Compositions and methods for monitoring and altering protein folding and solubility
|
US7666593B2
(en)
|
2005-08-26 |
2010-02-23 |
Helicos Biosciences Corporation |
Single molecule sequencing of captured nucleic acids
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
EP1998800A2
(de)
|
2006-01-18 |
2008-12-10 |
University Of Chicago |
Zusammensetzungen und verfahren in verbindung mit stayphylokokken-bakterienproteinen
|
US7397546B2
(en)
|
2006-03-08 |
2008-07-08 |
Helicos Biosciences Corporation |
Systems and methods for reducing detected intensity non-uniformity in a laser beam
|
US8088582B2
(en)
|
2006-04-06 |
2012-01-03 |
Ibis Biosciences, Inc. |
Compositions for the use in identification of fungi
|
WO2007127428A2
(en)
*
|
2006-04-28 |
2007-11-08 |
University Of Florida Research Foundation, Inc. |
Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery
|
WO2007140417A2
(en)
|
2006-05-31 |
2007-12-06 |
Sequenom, Inc. |
Methods and compositions for the extraction and amplification of nucleic acid from a sample
|
US7479550B2
(en)
*
|
2006-06-02 |
2009-01-20 |
The Board Of Regents Of The University Of Texas System |
Amyloid β gene vaccines
|
US8153369B2
(en)
|
2006-06-05 |
2012-04-10 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
ATE543097T1
(de)
|
2006-07-27 |
2012-02-15 |
Univ Maryland |
Zellulärer rezeptor für antiproliferativen faktor
|
AU2007353877B2
(en)
|
2006-09-14 |
2012-07-19 |
Ibis Biosciences, Inc. |
Targeted whole genome amplification method for identification of pathogens
|
US8481023B2
(en)
|
2006-09-15 |
2013-07-09 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
EP2089520B1
(de)
*
|
2006-11-29 |
2014-01-08 |
University of Iowa Research Foundation |
Alternative Exportwege für über einen Vektor exprimierte RNA-Interferenz
|
ATE555128T1
(de)
|
2006-11-30 |
2012-05-15 |
Res Dev Foundation |
Verbesserte immunglobulin-bibliotheken
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
AU2008213634B2
(en)
|
2007-02-08 |
2013-09-05 |
Sequenom, Inc. |
Nucleic acid-based tests for RhD typing, gender determination and nucleic acid quantification
|
US8871471B2
(en)
|
2007-02-23 |
2014-10-28 |
Ibis Biosciences, Inc. |
Methods for rapid forensic DNA analysis
|
CA2679954A1
(en)
|
2007-03-05 |
2008-09-12 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
AU2008230813B2
(en)
|
2007-03-26 |
2014-01-30 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
WO2008118324A2
(en)
|
2007-03-26 |
2008-10-02 |
Macrogenics, Inc. |
Composition and method of treating cancer with an anti-uroplakin ib antibody
|
AU2008247819B2
(en)
|
2007-05-01 |
2013-02-14 |
Research Development Foundation |
Immunoglobulin Fc libraries
|
US20100291544A1
(en)
*
|
2007-05-25 |
2010-11-18 |
Ibis Biosciences, Inc. |
Compositions for use in identification of strains of hepatitis c virus
|
US9598724B2
(en)
|
2007-06-01 |
2017-03-21 |
Ibis Biosciences, Inc. |
Methods and compositions for multiple displacement amplification of nucleic acids
|
US20110045456A1
(en)
*
|
2007-06-14 |
2011-02-24 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adventitious contaminant viruses
|
EP2195452B1
(de)
|
2007-08-29 |
2012-03-14 |
Sequenom, Inc. |
Verfahren und zusammensetzungen für die universelle grössenspezifische polymerasekettenreaktion
|
US20090180931A1
(en)
|
2007-09-17 |
2009-07-16 |
Sequenom, Inc. |
Integrated robotic sample transfer device
|
US8450106B2
(en)
*
|
2007-10-17 |
2013-05-28 |
The Ohio State University Research Foundation |
Oncolytic virus
|
US9273100B2
(en)
|
2007-11-09 |
2016-03-01 |
Board Of Trustees Of Michigan State University |
Use of Galerina marginata genes and proteins for peptide production
|
US9518097B2
(en)
*
|
2007-11-09 |
2016-12-13 |
Board Of Trustees Of Michigan State University |
Identification and use of genes encoding amatoxin and phallotoxin
|
EP2222344A4
(de)
*
|
2007-11-30 |
2012-11-07 |
Baylor College Medicine |
Impfstoffzusammensetzungen mit dendritischen zellen und ihre verwendung
|
BRPI0906429B1
(pt)
|
2008-01-10 |
2021-08-03 |
Research Development Foundation |
Método de identificação de uma infecção por e. chaffeensis em um indivíduo, uso de um ou mais polipeptídeo sintético e kit
|
US20110097704A1
(en)
*
|
2008-01-29 |
2011-04-28 |
Ibis Biosciences, Inc. |
Compositions for use in identification of picornaviruses
|
WO2009114543A2
(en)
|
2008-03-11 |
2009-09-17 |
Sequenom, Inc. |
Nucleic acid-based tests for prenatal gender determination
|
AU2009228312B2
(en)
|
2008-03-26 |
2015-05-21 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
DK2279253T3
(en)
|
2008-04-09 |
2017-02-13 |
Maxcyte Inc |
Construction and application of therapeutic compositions of freshly isolated cells
|
US20110177515A1
(en)
*
|
2008-05-30 |
2011-07-21 |
Ibis Biosciences, Inc. |
Compositions for use in identification of francisella
|
WO2009155103A2
(en)
*
|
2008-05-30 |
2009-12-23 |
Ibis Biosciences, Inc. |
Compositions for use in identification of tick-borne pathogens
|
WO2009148995A2
(en)
*
|
2008-06-02 |
2009-12-10 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adventitious viruses
|
EP3279314A1
(de)
|
2008-06-04 |
2018-02-07 |
Cellular Dynamics International, Inc. |
Verfahren zur herstellung von ips-zellen unter verwendung eines nicht-viralen ansatzes
|
WO2010019569A1
(en)
|
2008-08-12 |
2010-02-18 |
Cellular Dynamics International. Inc. |
Methods for the production of ips cells
|
US8912146B2
(en)
|
2008-08-18 |
2014-12-16 |
University Of Maryland, Baltimore |
Derivatives of APF and methods of use
|
EP2344893B1
(de)
|
2008-09-16 |
2014-10-15 |
Ibis Biosciences, Inc. |
Mikroplatten-handhabungssysteme und verfahren
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8148163B2
(en)
|
2008-09-16 |
2012-04-03 |
Ibis Biosciences, Inc. |
Sample processing units, systems, and related methods
|
US8476013B2
(en)
*
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
WO2010033599A2
(en)
|
2008-09-16 |
2010-03-25 |
Ibis Biosciences, Inc. |
Mixing cartridges, mixing stations, and related kits, systems, and methods
|
US20110200985A1
(en)
*
|
2008-10-02 |
2011-08-18 |
Rangarajan Sampath |
Compositions for use in identification of herpesviruses
|
WO2010039755A1
(en)
*
|
2008-10-02 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of members of the bacterial genus mycoplasma
|
WO2010039787A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of clostridium difficile
|
WO2010039775A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of members of the bacterial class alphaproteobacter
|
WO2010039870A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of neisseria, chlamydia, and/or chlamydophila bacteria
|
US20110190170A1
(en)
*
|
2008-10-03 |
2011-08-04 |
Ibis Biosciences, Inc. |
Compositions for use in identification of antibiotic-resistant bacteria
|
WO2010039848A2
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of streptococcus pneumoniae
|
EP2341929B1
(de)
|
2008-10-06 |
2017-01-25 |
University Of Chicago |
Zusammensetzungen und verfahren im zusammenhang mit bakteriellen emp proteinen
|
US8388904B1
(en)
|
2008-12-22 |
2013-03-05 |
Reactive Surfaces, Ltd., Llp |
Equipment decontamination system and method
|
US8645115B2
(en)
|
2008-12-22 |
2014-02-04 |
Trustees Of Boston University |
Modular nucleic acid-based circuits for counters, binary operations, memory and logic
|
EP2396661A4
(de)
|
2009-02-11 |
2013-10-30 |
Caris Mpi Inc |
Molekulare profilierung von tumoren
|
EP2396803A4
(de)
|
2009-02-12 |
2016-10-26 |
Ibis Biosciences Inc |
Ionisationssondenanordnungen
|
WO2010104798A1
(en)
|
2009-03-08 |
2010-09-16 |
Ibis Biosciences, Inc. |
Bioagent detection methods
|
WO2010107946A2
(en)
*
|
2009-03-18 |
2010-09-23 |
Sequenom, Inc. |
Use of thermostable endonucleases for generating reporter molecules
|
WO2010114842A1
(en)
|
2009-03-30 |
2010-10-07 |
Ibis Biosciences, Inc. |
Bioagent detection systems, devices, and methods
|
SI3281947T1
(sl)
|
2009-04-03 |
2020-07-31 |
The University Of Chicago |
Sestave in metode v zvezi z variantami proteina A (SPA)
|
EP3211095B1
(de)
|
2009-04-03 |
2019-01-02 |
Sequenom, Inc. |
Zusammensetzungen und verfahren für die herstellung von nukleinsäuren
|
KR101813464B1
(ko)
|
2009-06-05 |
2018-01-30 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
T 세포 및 조혈 세포의 재프로그래밍
|
WO2011008530A2
(en)
|
2009-06-29 |
2011-01-20 |
Luminex Corporation |
Chimeric primers with hairpin conformations and methods of using same
|
US9194877B2
(en)
|
2009-07-17 |
2015-11-24 |
Ibis Biosciences, Inc. |
Systems for bioagent indentification
|
WO2011008971A1
(en)
|
2009-07-17 |
2011-01-20 |
Ibis Biosciences, Inc. |
Lift and mount apparatus
|
US9409983B2
(en)
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
US9416409B2
(en)
*
|
2009-07-31 |
2016-08-16 |
Ibis Biosciences, Inc. |
Capture primers and capture sequence linked solid supports for molecular diagnostic tests
|
EP2462244B1
(de)
|
2009-08-06 |
2016-07-20 |
Ibis Biosciences, Inc. |
Basiszusammensetzungen ohne massebestimmung zur nukleinsäureerkennung
|
US20110053803A1
(en)
|
2009-08-26 |
2011-03-03 |
Xin Ge |
Methods for creating antibody libraries
|
US20110065111A1
(en)
*
|
2009-08-31 |
2011-03-17 |
Ibis Biosciences, Inc. |
Compositions For Use In Genotyping Of Klebsiella Pneumoniae
|
US9512481B2
(en)
|
2009-09-11 |
2016-12-06 |
The Regents Of The University Of Colorado, A Body Corporate |
Polymorphisms in the PDE3A gene
|
KR101838472B1
(ko)
|
2009-09-14 |
2018-03-15 |
신라젠(주) |
종양 용해 백시니아 바이러스 병용 암 치료요법
|
WO2011038002A1
(en)
|
2009-09-22 |
2011-03-31 |
Yale University |
Immunogenic epitopes as targets for universal cancer vaccines
|
EP2957641B1
(de)
|
2009-10-15 |
2017-05-17 |
Ibis Biosciences, Inc. |
Multiple-displacement-amplifikation
|
US20160186266A1
(en)
|
2009-10-27 |
2016-06-30 |
Carislife Sciences, Inc. |
Molecular profiling for personalized medicine
|
WO2011062962A2
(en)
|
2009-11-17 |
2011-05-26 |
The Trustees Of The University Of Pennsylvania |
Smndelta7 degron: novel compositions and methods of use
|
MX365946B
(es)
|
2009-12-10 |
2019-06-19 |
Turnstone Lp |
Rabdovirus oncolitico.
|
US9926593B2
(en)
|
2009-12-22 |
2018-03-27 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
EP2515899B1
(de)
|
2009-12-23 |
2016-05-25 |
ARCA biopharma, Inc. |
Verfahren und zusammensetzungen für herz-kreislauf-erkrankungen und -leiden
|
WO2011100508A2
(en)
|
2010-02-12 |
2011-08-18 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
US9758840B2
(en)
*
|
2010-03-14 |
2017-09-12 |
Ibis Biosciences, Inc. |
Parasite detection via endosymbiont detection
|
WO2011116276A2
(en)
|
2010-03-18 |
2011-09-22 |
Matthew Delisa |
Engineering correctly folded antibodies using inner membrane display of twin-arginine translocation intermediates
|
US20190300945A1
(en)
|
2010-04-05 |
2019-10-03 |
Prognosys Biosciences, Inc. |
Spatially Encoded Biological Assays
|
US10787701B2
(en)
|
2010-04-05 |
2020-09-29 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
|
CA2796601C
(en)
|
2010-04-19 |
2019-03-26 |
Research Development Foundation |
Rtef-1 variants and uses thereof
|
ES2670842T3
(es)
|
2010-06-15 |
2018-06-01 |
Cellular Dynamics International, Inc. |
Generación de células madre pluripotentes inducidas a partir de pequeños volúmenes de sangre periférica
|
JP6002128B2
(ja)
|
2010-07-02 |
2016-10-05 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
プロテインA(SpA)変種に関連する組成物および方法
|
CA2804595C
(en)
|
2010-07-07 |
2018-11-13 |
Cellular Dynamics International, Inc. |
Endothelial cell production by programming
|
EP2596128B1
(de)
|
2010-07-22 |
2015-04-22 |
President and Fellows of Harvard College |
Biologische klassierschaltungen mit mehrfacheingabe für zellen
|
CA2806858C
(en)
|
2010-08-04 |
2021-06-15 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized b cells
|
BR112013005711A2
(pt)
|
2010-09-08 |
2017-06-13 |
Univ Texas |
método para tratar um tumor, mutante, molécula de ácido nucleico isolada, construção de expressão, composição, e, método para administrar uma terapia
|
US9095540B2
(en)
|
2010-09-09 |
2015-08-04 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
JP6121910B2
(ja)
|
2011-01-04 |
2017-04-26 |
シラジェン バイオセラピューティクス インコーポレイテッド |
腫瘍溶解性ワクシニアウイルスの投与による腫瘍抗原に対する抗体の生成および腫瘍特異的補体依存性細胞傷害の生成
|
EP2673299B1
(de)
|
2011-02-07 |
2017-05-10 |
Research Development Foundation |
Manipulierte immunglobulin-fc-polypeptide
|
US9574179B2
(en)
|
2011-02-08 |
2017-02-21 |
Cellular Dynamics International, Inc. |
Hematopoietic precursor cell production by programming
|
WO2012158238A2
(en)
|
2011-02-28 |
2012-11-22 |
University Of Iowa Research Foundation |
Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
|
EP2683835B1
(de)
|
2011-03-08 |
2017-01-11 |
King Abdullah University Of Science And Technology |
Molekulares biomarker-set zur früherkennung von eierstockkrebs
|
JP6054371B2
(ja)
|
2011-04-06 |
2016-12-27 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
病原性疾患における細菌mamポリペプチドの調節
|
US9085631B2
(en)
|
2011-04-08 |
2015-07-21 |
Nov Vac APS |
Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
|
GB201106254D0
(en)
|
2011-04-13 |
2011-05-25 |
Frisen Jonas |
Method and product
|
KR102151656B1
(ko)
|
2011-04-28 |
2020-09-03 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
샘플과 연관된 폴리뉴클레오티드의 식별
|
WO2012149339A2
(en)
|
2011-04-29 |
2012-11-01 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
US9364532B2
(en)
|
2011-06-08 |
2016-06-14 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Compositions and methods for glioblastoma treatment
|
US20130040302A1
(en)
|
2011-07-11 |
2013-02-14 |
Thomas J. Burke |
Methods for cell reprogramming and genome engineering
|
CA2846486C
(en)
|
2011-07-12 |
2019-08-20 |
Philadelphia Health & Education Corporation |
Novel clostridium difficile dna vaccine
|
WO2013026015A1
(en)
|
2011-08-18 |
2013-02-21 |
Dana-Farber Cancer Institute, Inc. |
Muc1 ligand traps for use in treating cancers
|
WO2013036799A2
(en)
|
2011-09-09 |
2013-03-14 |
Fred Hutchinson Cancer Research Center |
Methods and compositions involving nkg2d inhibitors and cancer
|
EP2766388A1
(de)
|
2011-10-12 |
2014-08-20 |
Møller, Niels Iversen |
Peptide aus campylobacter jejuni und ihre verwendung bei der impfung
|
EP3269820A1
(de)
|
2011-12-22 |
2018-01-17 |
Ibis Biosciences, Inc. |
Kit für die amplifizierung einer sequenz aus einer ribonukleinsäure
|
SG10201606356YA
(en)
|
2012-02-02 |
2016-09-29 |
Univ Texas |
Adenoviruses expressing heterologous tumor-associated antigens
|
US9701959B2
(en)
|
2012-02-02 |
2017-07-11 |
Invenra Inc. |
High throughput screen for biologically active polypeptides
|
ES2930180T3
(es)
|
2012-03-02 |
2022-12-07 |
Sequenom Inc |
Métodos para enriquecer ácido nucleico canceroso a partir de una muestra biológica
|
WO2013155439A1
(en)
|
2012-04-13 |
2013-10-17 |
Massachusetts Institute Of Technology |
Analog and mixed-signal computation and circuits in living cells
|
BR112014026861A2
(pt)
|
2012-04-26 |
2018-05-15 |
Univ Chicago |
antígenos de estafilococos coagulase e métodos de seu uso
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
WO2014039513A2
(en)
|
2012-09-04 |
2014-03-13 |
The Trustees Of The University Of Pennsylvania |
Inhibition of diacylglycerol kinase to augment adoptive t cell transfer
|
WO2014065945A1
(en)
|
2012-10-23 |
2014-05-01 |
The Board Of Regents Of The University Of Texas System |
Antibodies with engineered igg fc domains
|
AU2013358998B2
(en)
|
2012-12-13 |
2019-04-18 |
Massachusetts Institute Of Technology |
Recombinase-based logic and memory systems
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
US9896728B2
(en)
|
2013-01-29 |
2018-02-20 |
Arcticrx Ltd. |
Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
|
RU2684211C2
(ru)
|
2013-02-21 |
2019-04-04 |
Тёрнстоун Лимитед Партнершип |
Композиция вакцины
|
US20140242595A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
ES2681948T3
(es)
|
2013-03-05 |
2018-09-17 |
Baylor College Of Medicine |
Células de acoplamiento para inmunoterapia
|
WO2014138315A1
(en)
|
2013-03-05 |
2014-09-12 |
Baylor College Of Medicine |
Heparanase expression in human t lymphocytes
|
EP3456818B1
(de)
|
2013-03-07 |
2020-05-20 |
Baylor College of Medicine |
Targeting von cd138 bei krebs
|
CN105189752B
(zh)
|
2013-03-08 |
2021-01-26 |
耶鲁大学 |
用于减少皮肤色素沉着的组合物和方法
|
WO2014164544A1
(en)
|
2013-03-09 |
2014-10-09 |
Baylor College Of Medicine |
Vascular-targeted t-cell therapy
|
EP3597774A1
(de)
|
2013-03-13 |
2020-01-22 |
Sequenom, Inc. |
Primer zur analyse der dna-methylierung
|
EP2972327B1
(de)
|
2013-03-13 |
2018-11-21 |
Trustees of Boston University |
Einstellbare steuerung von proteinabbau in synthetischen und endogenen bakteriellen systemen
|
WO2014210225A1
(en)
|
2013-06-25 |
2014-12-31 |
Prognosys Biosciences, Inc. |
Methods and systems for determining spatial patterns of biological targets in a sample
|
ES2902386T1
(es)
|
2013-07-01 |
2022-03-28 |
Massachusetts Inst Technology |
Funcionalización de bacterias endógenas
|
WO2015034872A2
(en)
|
2013-09-05 |
2015-03-12 |
Massachusetts Institute Of Technology |
Tuning microbial populations with programmable nucleases
|
US11819555B2
(en)
|
2013-09-09 |
2023-11-21 |
Figene, Llc |
Gene therapy for the regeneration of chondrocytes or cartilage type cells
|
BR112016007391A2
(pt)
|
2013-10-03 |
2017-08-01 |
Oklahoma Med Res Found |
biomarcadores da atividade, da intensidade e da fase aguda da doença lúpus eritematoso sistêmico
|
US10028902B2
(en)
|
2013-11-08 |
2018-07-24 |
Baylor Research Institute |
Nuclear localization of GLP-1 stimulates myocardial regeneration and reverses heart failure
|
WO2015070009A2
(en)
|
2013-11-08 |
2015-05-14 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
SG10201907841UA
(en)
|
2013-11-22 |
2019-10-30 |
Dnatrix Inc |
Adenovirus expressing immune cell stimulatory receptor agonist(s)
|
EP3074025A1
(de)
|
2013-11-27 |
2016-10-05 |
Baylor College Of Medicine |
Csgp4-spezifischer chimärer antigenrezeptor für krebs
|
EP4227685A3
(de)
|
2013-12-03 |
2024-02-28 |
Evaxion Biotech A/S |
Proteine und nukleinsäuren für impfstoffe gegen staphylococcus aureus
|
US9512406B2
(en)
|
2013-12-20 |
2016-12-06 |
The J. David Gladstone Institute, a testamentary trust established under the Will of J. David Gladstone |
Generating hepatocytes
|
SG10201807112XA
(en)
|
2013-12-30 |
2018-09-27 |
Atreca Inc |
Analysis of nucleic acids associated with single cells using nucleic acid barcodes
|
MX2016009954A
(es)
|
2014-01-29 |
2017-02-23 |
Dana Farber Cancer Inst Inc |
Anticuerpos contra el dominio extracelular de muc1-c (muc1-c/ecd).
|
US20170114382A1
(en)
|
2014-01-31 |
2017-04-27 |
Biogen Ma Inc. |
Methods of increasing protein production in mammalian cells
|
EP3736344A1
(de)
|
2014-03-13 |
2020-11-11 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
US20170107486A1
(en)
|
2014-04-21 |
2017-04-20 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
JP2017528430A
(ja)
|
2014-07-17 |
2017-09-28 |
ブライアン ジェイ ツェルニキCZERNIECKI, Brian, J. |
免疫に基づく療法のための、免疫原性mhcクラスiiペプチドの同定
|
EP3858991A1
(de)
|
2014-09-26 |
2021-08-04 |
Baylor College of Medicine |
Glypican-3-spezifische chimäre antigenrezeptoren für adoptive immuntherapie
|
US20180169211A1
(en)
|
2014-11-13 |
2018-06-21 |
Evaxion Biotech Aps |
Peptides derived from acinetobacter baumannii and their use in vaccination
|
WO2016086227A2
(en)
|
2014-11-26 |
2016-06-02 |
The Regents Of The University Of California |
Therapeutic compositions comprising transcription factors and methods of making and using the same
|
KR20170093248A
(ko)
|
2014-12-19 |
2017-08-14 |
다나-파버 캔서 인스티튜트 인크. |
탄산무수화효소 ix 특이적 키메라 항원 수용체 및 이의 사용 방법
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
US10434162B2
(en)
|
2015-01-12 |
2019-10-08 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae
|
MA41433A
(fr)
|
2015-01-26 |
2017-12-05 |
Baylor College Medicine |
Cellules immunitaires universelles pour l'immunothérapie anticancéreuse
|
CN107438665A
(zh)
|
2015-01-28 |
2017-12-05 |
沙特基础全球技术有限公司 |
用于高效生产生物燃料和/或生物质的方法和组合物
|
AU2016219511B2
(en)
|
2015-02-09 |
2020-11-12 |
Research Development Foundation |
Engineered immunoglobulin Fc polypeptides displaying improved complement activation
|
US11421229B2
(en)
|
2015-02-20 |
2022-08-23 |
Baylor College Of Medicine |
p63 inactivation for the treatment of heart failure
|
EP3070178B1
(de)
|
2015-03-20 |
2020-02-12 |
Albert-Ludwigs-Universität Freiburg |
Verfahren zur diagnose von brustkrebs
|
US10774374B2
(en)
|
2015-04-10 |
2020-09-15 |
Spatial Transcriptomics AB and Illumina, Inc. |
Spatially distinguished, multiplex nucleic acid analysis of biological specimens
|
WO2016172606A1
(en)
|
2015-04-23 |
2016-10-27 |
Baylor College Of Medicine |
Cd5 chimeric antigen receptor for adoptive t cell therapy
|
US10806761B2
(en)
|
2015-05-04 |
2020-10-20 |
The Brigham And Women's Hospital, Inc. |
Oncolytic HSV1 vector and methods of use
|
US11040094B2
(en)
|
2015-07-01 |
2021-06-22 |
Colleen M. O'Connor |
Compositions and methods for treating immunological dysfunction
|
WO2017005670A1
(en)
|
2015-07-04 |
2017-01-12 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
|
US10526408B2
(en)
|
2015-08-28 |
2020-01-07 |
Research Development Foundation |
Engineered antibody FC variants
|
WO2017059245A2
(en)
|
2015-09-30 |
2017-04-06 |
Trustees Of Boston University |
Deadman and passcode microbial kill switches
|
EP3362561A2
(de)
|
2015-10-16 |
2018-08-22 |
Astrazeneca AB |
Induzierbare modifikation eines zellgenoms
|
US10865381B2
(en)
|
2015-10-20 |
2020-12-15 |
FUJIFILM Cellular Dynamics, Inc. |
Multi-lineage hematopoietic precursor cell production by genetic programming
|
JP7023842B2
(ja)
|
2015-10-29 |
2022-02-22 |
テンプル ユニヴァーシティ - オブ ザ コモンウェルス システム オブ ハイアー エデュケーション |
Dnaポリメラーゼシータによる核酸の3’末端の修飾
|
US11207339B2
(en)
|
2015-10-30 |
2021-12-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Targeted cancer therapy
|
CA3003145A1
(en)
|
2015-10-30 |
2017-05-04 |
Gay M. Crooks |
Methods of generating t-cells from stem cells and immunotherapeutic methods using the t-cells
|
SI3370733T1
(sl)
|
2015-11-02 |
2021-11-30 |
Board Of Regents The University Of Texas System |
Postopek za aktivacijo CD40 in blokada imunske nadzorne točke
|
CA3004048A1
(en)
|
2015-11-03 |
2017-05-11 |
Regents Of The University Of Minnesota |
Cd200 inhibitors and methods of use thereof
|
CN108884159A
(zh)
|
2015-11-07 |
2018-11-23 |
茂体外尔公司 |
用于癌症治疗的包含肿瘤抑制基因治疗和免疫检查点阻断的组合物
|
AU2016354440B2
(en)
|
2015-11-09 |
2023-09-28 |
The Children's Hospital Of Philadelphia |
Glypican 2 as a cancer marker and therapeutic target
|
WO2017122096A1
(en)
|
2016-01-15 |
2017-07-20 |
Astrazeneca Ab |
Gene modification assays
|
JP2019508036A
(ja)
|
2016-02-16 |
2019-03-28 |
ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド |
免疫療法組成物及び方法
|
WO2017143076A1
(en)
|
2016-02-16 |
2017-08-24 |
Dana-Farber Cancer Institute, Inc. |
Chimeric antigen receptors and methods of use thereof
|
US10946084B2
(en)
|
2016-02-22 |
2021-03-16 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
|
US20190177391A1
(en)
|
2016-03-31 |
2019-06-13 |
Baylor Research Institute |
Angiopoietin-like protein 8 (angptl8)
|
US20190119364A1
(en)
|
2016-04-29 |
2019-04-25 |
The Regents Of The University Of Colorado, A Body Corporate |
Compounds and compositions useful for treating metabolic syndrome, and methods using same
|
JP7099967B2
(ja)
|
2016-07-01 |
2022-07-12 |
リサーチ ディベロップメント ファウンデーション |
幹細胞由来移植片からの増殖性細胞の排除
|
CA3031994A1
(en)
|
2016-07-29 |
2018-02-01 |
Juno Therapeutics, Inc. |
Methods for assessing the presence or absence of replication competent virus
|
WO2018035429A1
(en)
|
2016-08-18 |
2018-02-22 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of vla-4 and igf-1r
|
US11208664B2
(en)
|
2016-09-12 |
2021-12-28 |
Massachusetts Institute Of Technology |
Transcriptional sensor for bile acids in bacteroides thetaiotaomicron
|
EP3523423A1
(de)
|
2016-10-05 |
2019-08-14 |
FUJIFILM Cellular Dynamics, Inc. |
Verfahren zur gerichteten differenzierung pluripotenter stammzellen von homozygoten hla-immunzellen
|
CA3038690A1
(en)
|
2016-10-05 |
2018-04-12 |
FUJIFILM Cellular Dynamics, Inc. |
Generating mature lineages from induced pluripotent stem cells with mecp2 disruption
|
US20180127759A1
(en)
|
2016-10-28 |
2018-05-10 |
Massachusetts Institute Of Technology |
Dynamic genome engineering
|
CN109996809A
(zh)
|
2016-11-14 |
2019-07-09 |
诺华股份有限公司 |
与促融合蛋白minion相关的组合物、方法和治疗用途
|
WO2018111902A1
(en)
|
2016-12-12 |
2018-06-21 |
Multivir Inc. |
Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases
|
US11718648B2
(en)
|
2017-01-05 |
2023-08-08 |
Evaxion Biotech A/S |
Vaccines targeting Pseudomonas aeruginosa
|
EP3574114B1
(de)
|
2017-01-26 |
2022-06-29 |
Oklahoma Medical Research Foundation |
Biomarker für die krankheitsaktivität, die intensität und das auftreten von systemischem lupus erythematodes
|
US20200063127A1
(en)
|
2017-02-15 |
2020-02-27 |
Massachusetts Institute Of Technology |
Dna writers, molecular recorders and uses thereof
|
US11718860B2
(en)
|
2017-03-13 |
2023-08-08 |
Massachusetts Institute Of Technology |
Synthetic promoters
|
EP3595684A1
(de)
|
2017-03-17 |
2020-01-22 |
Senti Biosciences, Inc. |
Immunomodulierende zellkreise
|
US20200016207A1
(en)
|
2017-03-20 |
2020-01-16 |
Baylor College Of Medicine |
TRANSGENIC c-MPL PROVIDES LIGAND-DEPENDENT CO-STIMULATION AND CYTOKINE SIGNALS TO TCR-ENGINEERED T CELLS
|
US20180291443A1
(en)
*
|
2017-04-11 |
2018-10-11 |
Nugen Technologies, Inc. |
Library Quantitation And Qualification
|
SG10202111394XA
(en)
|
2017-04-13 |
2021-12-30 |
Senti Biosciences Inc |
Combinatorial cancer immunotherapy
|
DK3612557T3
(da)
|
2017-04-18 |
2022-04-19 |
Fujifilm Cellular Dynamics Inc |
Antigenspecifikke immuneffektorceller
|
KR20200032722A
(ko)
|
2017-07-27 |
2020-03-26 |
노파르티스 아게 |
부분절단효소 내성 trem2 변이체
|
WO2019027414A1
(en)
|
2017-07-31 |
2019-02-07 |
Massachusetts Institute Of Technology |
HIGH PERFORMANCE MULTIPLE INPUT MICRO-RNA DETECTORS AND USES THEREOF
|
WO2019027869A1
(en)
|
2017-07-31 |
2019-02-07 |
Massachusetts Institute Of Technology |
RNA-CLUSTER INDUCED TRANSCRIPT STABILIZER AND USES THEREOF
|
CA3089834A1
(en)
|
2018-01-30 |
2019-08-08 |
Children's Medical Center Corporation |
Production of botulinum neurotoxins using bacillus systems
|
WO2019152747A1
(en)
|
2018-01-31 |
2019-08-08 |
Juno Therapeutics, Inc. |
Methods and reagents for assessing the presence or absence of replication competent virus
|
WO2020036635A2
(en)
|
2018-03-19 |
2020-02-20 |
Multivir Inc. |
Methods and compositions comprising tumor suppressor gene therapy and cd122/cd132 agonists for the treatment of cancer
|
US20210169998A1
(en)
|
2018-05-01 |
2021-06-10 |
Orfoneuro Aps |
Treatment of neuronal ceroid lipofuscinosis
|
AR126019A1
(es)
|
2018-05-30 |
2023-09-06 |
Novartis Ag |
Anticuerpos frente a entpd2, terapias de combinación y métodos de uso de los anticuerpos y las terapias de combinación
|
WO2020028609A1
(en)
|
2018-08-01 |
2020-02-06 |
Massachusetts Institute Of Technology |
Phosphorylation-based mirna sensor
|
US11339395B2
(en)
|
2018-08-01 |
2022-05-24 |
Massachusetts Institute Of Technology |
RNA-based regulatory technologies for miRNA sensors
|
CN113164556A
(zh)
|
2018-08-30 |
2021-07-23 |
特纳亚治疗股份有限公司 |
用心肌蛋白和ascl1进行的心脏细胞重编程
|
UY38407A
(es)
|
2018-10-15 |
2020-05-29 |
Novartis Ag |
Anticuerpos estabilizadores de trem2
|
WO2020081204A1
(en)
|
2018-10-18 |
2020-04-23 |
Oklahoma Medical Research Foundation |
Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
|
US20220111031A1
(en)
|
2018-10-22 |
2022-04-14 |
Evaxion Biotech Aps |
Vaccines targeting M. catharrhalis
|
AU2019389175A1
(en)
|
2018-11-30 |
2021-06-10 |
Caris Mpi, Inc. |
Next-generation molecular profiling
|
WO2020123316A2
(en)
|
2018-12-10 |
2020-06-18 |
10X Genomics, Inc. |
Methods for determining a location of a biological analyte in a biological sample
|
US11926867B2
(en)
|
2019-01-06 |
2024-03-12 |
10X Genomics, Inc. |
Generating capture probes for spatial analysis
|
WO2020174044A1
(en)
|
2019-02-27 |
2020-09-03 |
Evaxion Biotech Aps |
Vaccines targeting h. influenzae
|
WO2020181058A1
(en)
|
2019-03-05 |
2020-09-10 |
Massachusetts Institute Of Technology |
Dna launched rna replicon system (drep) and uses thereof
|
US20200291428A1
(en)
|
2019-03-14 |
2020-09-17 |
Massachusetts Institute Of Technology |
Engineered herpes simplex virus-1 (hsv-1) vectors and uses thereof
|
WO2020209929A1
(en)
|
2019-04-09 |
2020-10-15 |
Massachusetts Institute Of Technology |
Mutant subgenomic promoter library and uses thereof
|
WO2020236597A1
(en)
|
2019-05-17 |
2020-11-26 |
Massachusetts Institute Of Technology |
Engineered post-poly a signal rna and uses thereof
|
EP3997226A1
(de)
|
2019-07-11 |
2022-05-18 |
Tenaya Therapeutics, Inc. |
Umprogrammierung von herzzellen mit mikrornas und anderen faktoren
|
AU2020317009A1
(en)
|
2019-07-19 |
2022-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric antigen receptors containing Glypican 2 binding domains
|
ES2960366T3
(es)
|
2019-08-09 |
2024-03-04 |
Univ Freiburg Albert Ludwigs |
Método para diagnosticar cáncer de mama
|
EP4025698A1
(de)
|
2019-09-03 |
2022-07-13 |
Sana Biotechnology, Inc. |
Cd24-assoziierte partikel und verwandte verfahren und verwendungen davon
|
WO2021046265A1
(en)
|
2019-09-06 |
2021-03-11 |
Generation Bio Co. |
Lipid nanoparticle compositions comprising closed-ended dna and cleavable lipids and methods of use thereof
|
WO2021048400A1
(en)
|
2019-09-13 |
2021-03-18 |
Evaxion Biotech Aps |
Method for identifying t-cell epitopes
|
WO2021048381A1
(en)
|
2019-09-13 |
2021-03-18 |
Evaxion Biotech Aps |
Method for identifying stable mhc binding peptides using mass spectrometry
|
EP4031578A1
(de)
|
2019-09-18 |
2022-07-27 |
Novartis AG |
Entpd2-antikörper, kombinationstherapien und verfahren zur verwendung der antikörper und kombinationstherapien
|
TW202124446A
(zh)
|
2019-09-18 |
2021-07-01 |
瑞士商諾華公司 |
與entpd2抗體之組合療法
|
US11492622B2
(en)
|
2019-09-26 |
2022-11-08 |
Massachusetts Institute Of Technology |
MicroRNA-based logic gates and uses thereof
|
WO2021062092A1
(en)
|
2019-09-26 |
2021-04-01 |
Massachusetts Institute Of Technology |
Trans-activated functional rna by strand displacement and uses thereof
|
WO2021058795A2
(en)
|
2019-09-27 |
2021-04-01 |
Stark Labs |
Senescent cell-associated antigen-binding domains, antibodies and chimeric antigen receptors comprising the same, and uses thereof
|
WO2021102411A1
(en)
|
2019-11-22 |
2021-05-27 |
Generation Bio Co. |
Ionizable lipids and nanoparticle compositions thereof
|
EP4069865A4
(de)
|
2019-12-02 |
2023-12-20 |
Caris MPI, Inc. |
Platinresistenztest für pan-krebs
|
WO2021113644A1
(en)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
|
US20230008380A1
(en)
|
2019-12-09 |
2023-01-12 |
University Of Georgia Research Foundation, Inc. |
M. tuberculosis ag85 proteins and methods of use
|
WO2021140123A1
(en)
|
2020-01-06 |
2021-07-15 |
Evaxion Biotech Aps |
Vaccines targeting neisseria gonorrhoeae
|
US11898205B2
(en)
|
2020-02-03 |
2024-02-13 |
10X Genomics, Inc. |
Increasing capture efficiency of spatial assays
|
US11891654B2
(en)
|
2020-02-24 |
2024-02-06 |
10X Genomics, Inc. |
Methods of making gene expression libraries
|
EP4110904A1
(de)
|
2020-02-28 |
2023-01-04 |
Takeda Pharmaceutical Company Limited |
Verfahren zur herstellung natürlicher killerzellen aus pluripotenten stammzellen
|
CN115552022A
(zh)
|
2020-03-02 |
2022-12-30 |
特纳亚治疗股份有限公司 |
由心肌细胞表达的微rna控制的基因载体
|
IL296662A
(en)
|
2020-03-24 |
2022-11-01 |
Generation Bio Co |
Non-viral DNA vectors and their use for expression of Gauche cure
|
KR20230003477A
(ko)
|
2020-03-24 |
2023-01-06 |
제너레이션 바이오 컴퍼니 |
비-바이러스성 dna 벡터 및 인자 ix 치료제 발현을 위한 이의 용도
|
JP2023520359A
(ja)
|
2020-03-25 |
2023-05-17 |
エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム |
放射性核種イメージングのためのレポーター系
|
JP2023521663A
(ja)
|
2020-03-31 |
2023-05-25 |
サナ バイオテクノロジー,インコーポレイテッド |
標的化脂質粒子及び組成物ならびにその使用
|
EP4242325A3
(de)
|
2020-04-22 |
2023-10-04 |
10X Genomics, Inc. |
Verfahren zur räumlichen analyse unter verwendung von gezieltem rna-abbau
|
US20230190871A1
(en)
|
2020-05-20 |
2023-06-22 |
Sana Biotechnology, Inc. |
Methods and compositions for treatment of viral infections
|
EP4153775A1
(de)
|
2020-05-22 |
2023-03-29 |
10X Genomics, Inc. |
Simultane räumlich-zeitliche messung der genexpression und der zellaktivität
|
IL298254A
(en)
|
2020-05-29 |
2023-01-01 |
Fujifilm Cellular Dynamics Inc |
Double layer of retinal pigment epithelium and photoreceptors and their uses
|
CN116033912A
(zh)
|
2020-05-29 |
2023-04-28 |
富士胶片细胞动力公司 |
视网膜色素上皮和感光器双细胞聚集物及其使用方法
|
US11761038B1
(en)
|
2020-07-06 |
2023-09-19 |
10X Genomics, Inc. |
Methods for identifying a location of an RNA in a biological sample
|
JP2023540705A
(ja)
|
2020-08-28 |
2023-09-26 |
サナ バイオテクノロジー,インコーポレイテッド |
修飾された抗ウイルス結合剤
|
US11926822B1
(en)
|
2020-09-23 |
2024-03-12 |
10X Genomics, Inc. |
Three-dimensional spatial analysis
|
US11781156B2
(en)
|
2020-10-09 |
2023-10-10 |
Tenaya Therapeutics, Inc. |
Plakophillin-2 gene therapy methods and compositions
|
US11827935B1
(en)
|
2020-11-19 |
2023-11-28 |
10X Genomics, Inc. |
Methods for spatial analysis using rolling circle amplification and detection probes
|
WO2022120019A2
(en)
|
2020-12-02 |
2022-06-09 |
Massachusetts Institute Of Technology |
A tunable phosphorylation-based feedback controller of mammalian gene expression
|
WO2022140028A1
(en)
*
|
2020-12-21 |
2022-06-30 |
10X Genomics, Inc. |
Methods, compositions, and systems for capturing probes and/or barcodes
|
WO2022155521A1
(en)
|
2021-01-15 |
2022-07-21 |
Board Of Regents, The University Of Texas System |
A trans-complementation system for sars-cov-2
|
CA3202849A1
(en)
|
2021-02-09 |
2022-08-18 |
University Of Houston System |
Oncolytic virus for systemic delivery and enhanced anti-tumor activities
|
IL308404A
(en)
|
2021-04-27 |
2024-01-01 |
Generation Bio Co |
Non-viral DNA vectors expressing therapeutic antibodies and uses thereof
|
WO2022232286A1
(en)
|
2021-04-27 |
2022-11-03 |
Generation Bio Co. |
Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof
|
CN117242173A
(zh)
|
2021-05-03 |
2023-12-15 |
安斯泰来再生医药协会 |
产生成熟角膜内皮细胞的方法
|
EP4334354A1
(de)
|
2021-05-06 |
2024-03-13 |
Dana-Farber Cancer Institute, Inc. |
Antikörper gegen alk und verfahren zur verwendung davon
|
TW202309268A
(zh)
|
2021-05-07 |
2023-03-01 |
安斯泰來再生醫藥協會 |
產生成熟肝細胞的方法
|
EP4347623A1
(de)
|
2021-05-26 |
2024-04-10 |
Evaxion Biotech A/S |
Impfung gegen intrazelluläre pathogene
|
AU2022280051A1
(en)
|
2021-05-26 |
2023-11-23 |
FUJIFILM Cellular Dynamics, Inc. |
Methods to prevent rapid silencing of genes in pluripotent stem cells
|
IL308836A
(en)
|
2021-05-28 |
2024-01-01 |
Sana Biotechnology Inc |
Lipid Particles Containing Baboon Truncated Endogenous Retrovirus (BAEV) Envelope Glycoprotein and Related Methods and Uses
|
KR20240023420A
(ko)
|
2021-06-14 |
2024-02-21 |
제너레이션 바이오 컴퍼니 |
양이온성 지질 및 이의 조성물
|
CN117813374A
(zh)
|
2021-06-15 |
2024-04-02 |
武田药品工业株式会社 |
从多能干细胞产生自然杀伤细胞的方法
|
CA3224564A1
(en)
|
2021-07-05 |
2023-01-12 |
Andreas Holm MATTSSON |
Vaccines targeting neisseria gonorrhoeae
|
WO2023034489A1
(en)
|
2021-09-01 |
2023-03-09 |
10X Genomics, Inc. |
Methods, compositions, and kits for blocking a capture probe on a spatial array
|
TW202342757A
(zh)
|
2021-12-17 |
2023-11-01 |
美商薩那生物科技公司 |
經修飾副黏液病毒科附著醣蛋白
|
WO2023114543A2
(en)
|
2021-12-17 |
2023-06-22 |
Dana-Farber Cancer Institute, Inc. |
Platform for antibody discovery
|
WO2023114544A1
(en)
|
2021-12-17 |
2023-06-22 |
Dana-Farber Cancer Institute, Inc. |
Antibodies and uses thereof
|
WO2023115039A2
(en)
|
2021-12-17 |
2023-06-22 |
Sana Biotechnology, Inc. |
Modified paramyxoviridae fusion glycoproteins
|
WO2023172694A1
(en)
|
2022-03-09 |
2023-09-14 |
Dana-Farber Cancer Institute, Inc. |
Genetically engineered b cells and methods of use thereof
|
WO2023177655A1
(en)
|
2022-03-14 |
2023-09-21 |
Generation Bio Co. |
Heterologous prime boost vaccine compositions and methods of use
|
US20230295661A1
(en)
|
2022-03-16 |
2023-09-21 |
University Of Houston System |
Persistent hsv gene delivery system
|
WO2023201207A1
(en)
|
2022-04-11 |
2023-10-19 |
Tenaya Therapeutics, Inc. |
Adeno-associated virus with engineered capsid
|
WO2023215860A1
(en)
|
2022-05-05 |
2023-11-09 |
University Of Rochester |
Modified bacteria and methods of use for bioglass microlenses
|
WO2023214346A1
(en)
|
2022-05-06 |
2023-11-09 |
Novartis Ag |
Novel recombinant aav vp2 fusion polypeptides
|
WO2023239940A1
(en)
|
2022-06-10 |
2023-12-14 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
WO2024006911A1
(en)
|
2022-06-29 |
2024-01-04 |
FUJIFILM Holdings America Corporation |
Ipsc-derived astrocytes and methods of use thereof
|
WO2024040222A1
(en)
|
2022-08-19 |
2024-02-22 |
Generation Bio Co. |
Cleavable closed-ended dna (cedna) and methods of use thereof
|
WO2024064838A1
(en)
|
2022-09-21 |
2024-03-28 |
Sana Biotechnology, Inc. |
Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof
|